Femoston 1mg/10mg #28

Femoston instruction

Reed more and buy Femoston on this page online

The drug Femoston 1/10 belongs to the group of antimycotics and is prescribed to women during menopause.

Composition and form of release

The preparation Femoston 1/10 is available in the form of tablets coated with a film membrane, of two kinds.
The composition of 1 white tablet includes 1 mg of Estradiol, 2 tablets included 1 mg of Estradiol and 10 mg of Dydrogesterone.
The composition of 1 tablet of gray color includes 2 mg of Estradiol, 2 tablets contains 10 mg of Dydrogesterone. In addition, the preparation includes a number of auxiliary substances, including lactose monohydrate.
The tablets are packed in a blister pack of 28 pieces, in a cardboard box with the attached detailed instructions.

Indications for use

Tablets Femoston 1/10 are prescribed to women for treatment and prevention of the following conditions:
    hormonal disorders in the period of menopause caused by age or transferred surgical interventions on the organs of the reproductive system;
    osteoporosis on the background of menopausal hormonal changes.

Contraindications

The drug has a number of contraindications, so before starting treatment, it is always necessary to consult a doctor and read the attached instructions. Femoden tablets should not be taken orally if there are one or more conditions:
    pregnancy - established or suspected;
    the period of breastfeeding;
    suspected breast cancer or diagnosed cancer;
    estrogen-dependent malignant neoplasms - identified or suspected;
    pathological proliferation of endometrial tissue;
    bleeding from the vagina of an unexplained etiology;
    venous thromboembolism, including deep vein thrombosis and pulmonary vascular thromboembolism;
    liver disease, accompanied by a violation of the function of the body;
    individual intolerance to the components of the drug;
    porphyria.

Relative contraindications to taking the drug are:

    endometriosis of the uterus;
    diabetes;
    cases of breast cancer in the genus by the female line;
    migraine;
    systemic lupus erythematosus;
    epilepsy;
    kidney failure;
    otosclerosis;
    bronchial asthma;
    cholelithiasis.

Dosing and Administration

Preparation Themiston 1/10 rinima 1 tablet once a day at exactly the same time of day. The drug can be taken regardless of food, washed down with a sufficient amount of water.
In the first half of the menstrual cycle (with a cycle of 28 days) take 1 tablet of white color, the remaining 14 days of the cycle take 1 tablet of gray color.
Women who have not had menstruation for more than 1 year because of hormonal disorders, treatment with the drug can begin any day.

Use in pregnancy and lactation

The drug Femoston is contraindicated for use during pregnancy. If a woman suspects pregnancy, then it is necessary to check with a gynecologist.
The drug should not be taken during breastfeeding, as the active substances of the tablets can be released with milk and enter the body of the child. If therapy is necessary, lactation should be interrupted and the child transferred to artificial feeding with a milk formula.

Side effects

Against the background of taking Femoston tablets in patients with increased individual sensitivity to the components of the drug, the following side effects may develop:
    on the part of the reproductive system - nagrubanie and soreness of the mammary glands, abundant discharge of blood from the vagina, not associated with menstruation, the formation and progression of erosion of the cervix, dysmenorrhea, enlargement of the mammary glands, changes in libido;
    from the digestive tract - stomach pain, nausea, bile stasis and gallbladder inflammation, liver function abnormalities, vomiting, stool disorders;
    from the side of the nervous system - headaches, migraine, irritability, asthenia, chorea, insomnia;
    from the cardiovascular system - ischemia of the heart muscle, the development of myocardial infarction, venous thromboembolism;
    from hemopoiesis - hemolytic anemia;
    allergic reactions - urticaria, skin itching, rash, erythema nodosum, in rare cases development of angioedema.
With the development of one or more side effects in menopause, you should consult your doctor to resolve the issue of discontinuing therapy.

Overdose

With a deliberate increase in the dose indicated in the instructions or a prolonged uncontrolled intake of the drug, the patient develops signs of an overdose that clinically show an increase in the side effects described above, severe drowsiness, dizziness.
When the signs of an overdose develop, the drug is immediately stopped, the woman is washed with a stomach and, if necessary, performs symptomatic treatment.

Interaction with other medicinal products

With the simultaneous administration of Femoston with barbiturates, rifampicin, carbamazepine, phenytoin, the therapeutic effect of Femoston may be weakened.
Preparations, which include an extract of St. John's wort, can stimulate the exchange of estrogens and progestogens.

special instructions

During the intake of the drug, women should periodically undergo a preventive checkup with a gynecologist and mammologist. When there are painful seals in the mammary gland, discharge from the nipple with pressure should immediately consult a gynecologist.
Against the background of therapy with the drug, you should periodically take a blood test for clotting. At a risk of developing thromboembolism, a combination of Femoston therapy and anticoagulants is possible.
If severe headaches or migraine attacks occur against the background of drug treatment, stop taking the pills and seek medical advice immediately.
At the initial stage of therapy with the drug, a woman may have breakthrough uterine bleeding that is not associated with menstruation. In this case, you need to see a doctor for a dose adjustment. If, in spite of the dose adjustment, bleeding continues, then the therapy is stopped until the cause of this condition is determined.
The drug has no effect on the central nervous system and the speed of psychomotor reactions.

Storage conditions

Keep the tablets out of the reach of children, at a temperature of no higher than 30 degrees. The shelf life of the drug is indicated on the packaging and is 3 years from the date of manufacture. Do not use the tablet after the expiration date.